ANNEX III, Directive (EU) 2005/61

In force

Reporting establishment

Report identification

Reporting date (year/month/day)

Date of serious adverse event (year/month/day)

Serious adverse event, which may affect quality and safety of blood component due to a deviation in: | Specification

Product defect | Equipment failure | Human error |

Other

(specify)

Whole blood collection | | | |

Apheresis collection | | | |

Testing of donations | | | |

Processing | | | |

Storage | | | |

Distribution | | | |

Materials | | | |

Others (specify) | | | |

Reporting establishment

Report identification

Confirmation date(year/month/day)

Date of serious adverse event(year/month/day)

Root cause analysis (details)

Corrective measures taken (details)

Reporting establishment

Reporting period

1 January-31 December (year)

Total number of blood and blood components processed:

Serious adverse event, affecting quality and safety of blood component due to a deviation in: | Total number | Specification

Product defect | Equipment failure | Human error |

Other

(specify)

Whole blood collection | | | | |

Apheresis collection | | | | |

Testing of donations | | | | |

Processing | | | | |

Storage | | | | |

Distribution | | | | |

Materials | | | | |

Others (specify) | | | | |